Delivery Order SPE2DB20D1110-SPE2DB24FJ72W
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product. The $1,430.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 10, 2023, with a completion date of January 11, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.07 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the pharmaceutical product CORLANOR 5 MG TABLET 60S, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,456.26 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 29, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $5,465.20 firm fixed price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a medication, with a performance period extending through June 13, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,648.58 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on March 1, 2024. This award does not utilize a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- This federal contract award, valued at $1,341.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025, and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,678.47 and is a firm fixed price delivery order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set aside and is open to full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,893.93, is for the delivery of the medication Corlanor 7.5 mg tablets. The contract has a period of performance through December 1, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,114.52 firm-fixed-price delivery order contract is for the supply of CORLANOR 5 MG TABLET 60S, a cardiovascular medication. The contract is not designated as a set-aside and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,269.30, is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 8, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FJ72WDelivery Order
This federal contract award is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,733.87, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 8, 2023. The contract was awarded on November 7, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/7/23 |